Cargando…

A Real World 10-Year Experience With Vascular Closure Devices and Large-Bore Access in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation

Transcatheter aortic valve replacement (TAVR) has established itself as a safe and efficient treatment option in patients with severe aortic valve stenosis, regardless of the underlying surgical risk. Widespread adoption of transfemoral procedures led to more patients than ever being eligible for TA...

Descripción completa

Detalles Bibliográficos
Autores principales: Heitzinger, Gregor, Brunner, Christina, Koschatko, Sophia, Dannenberg, Varius, Mascherbauer, Katharina, Halavina, Kseniya, Doná, Carolina, Koschutnik, Matthias, Spinka, Georg, Nitsche, Christian, Mach, Markus, Andreas, Martin, Wolf, Florian, Loewe, Christian, Neumayer, Christoph, Gschwandtner, Michael, Willfort-Ehringer, Andrea, Winter, Max-Paul, Lang, Irene M., Bartko, Philipp E., Hengstenberg, Christian, Goliasch, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814307/
https://www.ncbi.nlm.nih.gov/pubmed/35127860
http://dx.doi.org/10.3389/fcvm.2021.791693
_version_ 1784645025368375296
author Heitzinger, Gregor
Brunner, Christina
Koschatko, Sophia
Dannenberg, Varius
Mascherbauer, Katharina
Halavina, Kseniya
Doná, Carolina
Koschutnik, Matthias
Spinka, Georg
Nitsche, Christian
Mach, Markus
Andreas, Martin
Wolf, Florian
Loewe, Christian
Neumayer, Christoph
Gschwandtner, Michael
Willfort-Ehringer, Andrea
Winter, Max-Paul
Lang, Irene M.
Bartko, Philipp E.
Hengstenberg, Christian
Goliasch, Georg
author_facet Heitzinger, Gregor
Brunner, Christina
Koschatko, Sophia
Dannenberg, Varius
Mascherbauer, Katharina
Halavina, Kseniya
Doná, Carolina
Koschutnik, Matthias
Spinka, Georg
Nitsche, Christian
Mach, Markus
Andreas, Martin
Wolf, Florian
Loewe, Christian
Neumayer, Christoph
Gschwandtner, Michael
Willfort-Ehringer, Andrea
Winter, Max-Paul
Lang, Irene M.
Bartko, Philipp E.
Hengstenberg, Christian
Goliasch, Georg
author_sort Heitzinger, Gregor
collection PubMed
description Transcatheter aortic valve replacement (TAVR) has established itself as a safe and efficient treatment option in patients with severe aortic valve stenosis, regardless of the underlying surgical risk. Widespread adoption of transfemoral procedures led to more patients than ever being eligible for TAVR. This increase in procedural volumes has also stimulated the use of vascular closure devices (VCDs) for improved access site management. In a single-center examination, we investigated 871 patients that underwent transfemoral TAVR from 2010 to 2020 and assessed vascular complications according to the Valve Academic Research Consortium (VARC) III recommendations. Patients were grouped by the VCD and both, vascular closure success and need for intervention were analyzed. In case of a vascular complication, the type of intervention was investigated for all VCDs. The Proglide VCD was the most frequently used device (n = 670), followed by the Prostar device (n = 112). Patients were old (median age 83 years) and patients suffered from high comorbidity burden (60% coronary artery disease, 30% type II diabetes, 40% atrial fibrillation). The overall rate of major complications amounted to 4.6%, it was highest in the Prostar group (9.6%) and lowest in the Manta VCD group (1.1% p = 0.019). The most frequent vascular complications were bleeding and hematoma (n = 110, 13%). In case a complication occurred, 72% of patients did not need any further intervention other than manual compression or pressure bandages. The rate of surgical intervention after complication was highest in the Prostar group (n = 15, 29%, p = 0.001). Temporal trends in VCD usage highlight the rapid adoption of the Proglide system after introduction at our institution. In recent years VCD alternatives, utilizing other closure techniques, such as the Manta device emerged and increased vascular access site management options. This 10-year single-center experience demonstrates high success rates for all VCDs. Despite successful closure, a significant number of patients does experience minor vascular complications, in particular bleeding and hematoma. However, most complications do not require surgical or endovascular intervention. Temporal trends display a marked increase in TAVR procedures and highlight the need for more refined vascular access management strategies.
format Online
Article
Text
id pubmed-8814307
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88143072022-02-05 A Real World 10-Year Experience With Vascular Closure Devices and Large-Bore Access in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation Heitzinger, Gregor Brunner, Christina Koschatko, Sophia Dannenberg, Varius Mascherbauer, Katharina Halavina, Kseniya Doná, Carolina Koschutnik, Matthias Spinka, Georg Nitsche, Christian Mach, Markus Andreas, Martin Wolf, Florian Loewe, Christian Neumayer, Christoph Gschwandtner, Michael Willfort-Ehringer, Andrea Winter, Max-Paul Lang, Irene M. Bartko, Philipp E. Hengstenberg, Christian Goliasch, Georg Front Cardiovasc Med Cardiovascular Medicine Transcatheter aortic valve replacement (TAVR) has established itself as a safe and efficient treatment option in patients with severe aortic valve stenosis, regardless of the underlying surgical risk. Widespread adoption of transfemoral procedures led to more patients than ever being eligible for TAVR. This increase in procedural volumes has also stimulated the use of vascular closure devices (VCDs) for improved access site management. In a single-center examination, we investigated 871 patients that underwent transfemoral TAVR from 2010 to 2020 and assessed vascular complications according to the Valve Academic Research Consortium (VARC) III recommendations. Patients were grouped by the VCD and both, vascular closure success and need for intervention were analyzed. In case of a vascular complication, the type of intervention was investigated for all VCDs. The Proglide VCD was the most frequently used device (n = 670), followed by the Prostar device (n = 112). Patients were old (median age 83 years) and patients suffered from high comorbidity burden (60% coronary artery disease, 30% type II diabetes, 40% atrial fibrillation). The overall rate of major complications amounted to 4.6%, it was highest in the Prostar group (9.6%) and lowest in the Manta VCD group (1.1% p = 0.019). The most frequent vascular complications were bleeding and hematoma (n = 110, 13%). In case a complication occurred, 72% of patients did not need any further intervention other than manual compression or pressure bandages. The rate of surgical intervention after complication was highest in the Prostar group (n = 15, 29%, p = 0.001). Temporal trends in VCD usage highlight the rapid adoption of the Proglide system after introduction at our institution. In recent years VCD alternatives, utilizing other closure techniques, such as the Manta device emerged and increased vascular access site management options. This 10-year single-center experience demonstrates high success rates for all VCDs. Despite successful closure, a significant number of patients does experience minor vascular complications, in particular bleeding and hematoma. However, most complications do not require surgical or endovascular intervention. Temporal trends display a marked increase in TAVR procedures and highlight the need for more refined vascular access management strategies. Frontiers Media S.A. 2022-01-21 /pmc/articles/PMC8814307/ /pubmed/35127860 http://dx.doi.org/10.3389/fcvm.2021.791693 Text en Copyright © 2022 Heitzinger, Brunner, Koschatko, Dannenberg, Mascherbauer, Halavina, Doná, Koschutnik, Spinka, Nitsche, Mach, Andreas, Wolf, Loewe, Neumayer, Gschwandtner, Willfort-Ehringer, Winter, Lang, Bartko, Hengstenberg and Goliasch. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Heitzinger, Gregor
Brunner, Christina
Koschatko, Sophia
Dannenberg, Varius
Mascherbauer, Katharina
Halavina, Kseniya
Doná, Carolina
Koschutnik, Matthias
Spinka, Georg
Nitsche, Christian
Mach, Markus
Andreas, Martin
Wolf, Florian
Loewe, Christian
Neumayer, Christoph
Gschwandtner, Michael
Willfort-Ehringer, Andrea
Winter, Max-Paul
Lang, Irene M.
Bartko, Philipp E.
Hengstenberg, Christian
Goliasch, Georg
A Real World 10-Year Experience With Vascular Closure Devices and Large-Bore Access in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation
title A Real World 10-Year Experience With Vascular Closure Devices and Large-Bore Access in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation
title_full A Real World 10-Year Experience With Vascular Closure Devices and Large-Bore Access in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation
title_fullStr A Real World 10-Year Experience With Vascular Closure Devices and Large-Bore Access in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation
title_full_unstemmed A Real World 10-Year Experience With Vascular Closure Devices and Large-Bore Access in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation
title_short A Real World 10-Year Experience With Vascular Closure Devices and Large-Bore Access in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation
title_sort real world 10-year experience with vascular closure devices and large-bore access in patients undergoing transfemoral transcatheter aortic valve implantation
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814307/
https://www.ncbi.nlm.nih.gov/pubmed/35127860
http://dx.doi.org/10.3389/fcvm.2021.791693
work_keys_str_mv AT heitzingergregor arealworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT brunnerchristina arealworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT koschatkosophia arealworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT dannenbergvarius arealworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT mascherbauerkatharina arealworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT halavinakseniya arealworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT donacarolina arealworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT koschutnikmatthias arealworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT spinkageorg arealworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT nitschechristian arealworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT machmarkus arealworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT andreasmartin arealworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT wolfflorian arealworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT loewechristian arealworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT neumayerchristoph arealworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT gschwandtnermichael arealworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT willfortehringerandrea arealworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT wintermaxpaul arealworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT langirenem arealworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT bartkophilippe arealworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT hengstenbergchristian arealworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT goliaschgeorg arealworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT heitzingergregor realworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT brunnerchristina realworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT koschatkosophia realworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT dannenbergvarius realworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT mascherbauerkatharina realworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT halavinakseniya realworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT donacarolina realworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT koschutnikmatthias realworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT spinkageorg realworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT nitschechristian realworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT machmarkus realworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT andreasmartin realworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT wolfflorian realworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT loewechristian realworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT neumayerchristoph realworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT gschwandtnermichael realworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT willfortehringerandrea realworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT wintermaxpaul realworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT langirenem realworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT bartkophilippe realworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT hengstenbergchristian realworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation
AT goliaschgeorg realworld10yearexperiencewithvascularclosuredevicesandlargeboreaccessinpatientsundergoingtransfemoraltranscatheteraorticvalveimplantation